| NCT ID | NCT07634016 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Julia Tatjana Maul |
| Condition | Psoriasis (PsO) |
| Study Type | OBSERVATIONAL |
| Enrollment | 9,600 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 9,600 participants in total. It began in 2025-01-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Global Healthcare Study on Psoriasis (GHSP) is an international, multicenter observational study hosted by the University of Zurich (UZH) investigating healthcare access, treatment patterns, disease severity, and quality of life in patients with psoriasis. The study collects standardized clinical data from routine medical records to identify disparities in healthcare delivery and outcomes across different healthcare systems.
Eligibility Criteria
Inclusion Criteria: * Signed General Consent Form, or equivalent document * Confirmed diagnosis of Psoriasis Exclusion Criteria: * Inability to provide informed consent. * Datasets with ambiguous or unclear diagnosis.
Contact & Investigator
Julia-Tatjana Maul, Prof. Dr. med.
PRINCIPAL INVESTIGATOR
University of Zurich
Frequently Asked Questions
Who can join the NCT07634016 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying Psoriasis (PsO). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07634016 currently recruiting?
Yes, NCT07634016 is actively recruiting participants. Contact the research team at julia-tatjana.maul@uzh.ch for enrollment information.
Where is the NCT07634016 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT07634016 clinical trial?
NCT07634016 is sponsored by Julia Tatjana Maul. The principal investigator is Julia-Tatjana Maul, Prof. Dr. med. at University of Zurich. The trial plans to enroll 9,600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.